| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |